NCT07651085 · ACTIVE NOT RECRUITING
Biomarkers in Alzheimer's and Parkinson's Diseases for IA
This observational study is collecting biological samples, brain scans, EEG readings, and cognitive test results from people with Alzheimer's disease, Parkinson's disease, or mild cognitive impairment. The goal is to find biomarkers — measurable signals in blood, saliva, brain activity, and sleep patterns — that might predict or correlate with cognitive decline. No phase is listed, meaning no experimental drug or device treatment is being tested here.
You may qualify if
- The subject must be over 60 years of age;
- The Subject must have a full understanding of the Italian language;
- The subject is available to participate in the phase telemonitoring.
You're excluded if
- Inability to sign the informed consent;
- Severe dementia;
- Other concomitant diseases;
- Inability to participate in study procedures;
- Presence of arrhythmia, heart failure or previous heart attack, peripheral vascular disease or impaired circulation, valvular disease (diseases affecting the aortic valve), other diseases known conditions, end-stage renal disease (ESRD), diabetes, neurological disorders (e.g example, tremors), bleeding disorder or taking prescribed anticoagulants, tattoo(s) on the wrist where you will wear the Samsung Galaxy Watch, you will have an implanted pacemaker, a defibrillator implanted heart or other implanted electronic devices.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-06-16